This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ian R. Reid, MD; Diana J. Wattie, RN; Margaret C. Evans; Joanne P. Stapleton, RGON

Arch Intern Med. 1996;156(11):1173-1177.

Abstract
Background
Treatment with glucocorticoid drugs is a valuable therapy, but the use of these drugs is associated with major side effects, including osteoporosis, muscle wasting, and obesity. In men who take glucocorticoids, circulating testosterone concentrations are reduced, and this might contribute to the changes in bone and soft-tissue mass.

Objective
To assess the effect of testosterone replacement on these above-mentioned parameters in glucocorticoid-treated men.

Methods
Fifteen asthmatic men who were receiving long-term glucocorticoid treatment were randomly allocated to receive therapy with testosterone esters (30 mg of proprionate, 60 mg of phenylprionate, 60 mg of isocaproate, and 100 mg of decanoate [Sustanon]) (250-mg/mo intramuscular depot injection) or to act as control subjects during 12 months. After a washout period for those men who were receiving testosterone, the groups were then crossed over and studied for a further 12 months. Bone density and body composition were assessed by dual-energy, x-ray absorptiometry. Paired or unpaired 2-tailed t tested were calculated. Unless otherwise stated, all values are given as mean±SEM.

Results
Bone density in the lumbar spine increased 5.0%±1.4% (mean±SEM) (P=.005) during testosterone supplementation, but it did not change during the control period (between-groups difference, P=.05). These changes were accompanied by a decrease in the indexes of bone turnover. There was a gain in body fat mass (2.1±0.06 kg, P=.01) and a loss of lean body mass (1.4±0.5 kg, P=.02) during the control period, with both changes being reversed by testosterone treatment (P<.03).

Conclusion
Testosterone treatment reverses the deleterious effects of glucocorticoid drugs on skeletal and soft tissues in men.

(Arch Intern Med. 1996;156:1173-1177)

Author Affiliations
From the Department of Medicine, University of Auckland (New Zealand).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of glucocorticoid-induced osteoporosis
Mazziotti et al.
Therapeutic Advances in Musculoskeletal Diseases 2009;1:27-34.
ABSTRACT  

Expression of the Muscle Atrophy Factor Muscle Atrophy F-Box Is Suppressed by Testosterone
Zhao et al.
Endocrinology 2008;149:5449-5460.
ABSTRACT | FULL TEXT  

Osteoporosis in Men
Khosla et al.
Endocr. Rev. 2008;29:441-464.
ABSTRACT | FULL TEXT  

Identification of Androgen Response Elements in the Insulin-Like Growth Factor I Upstream Promoter
Wu et al.
Endocrinology 2007;148:2984-2993.
ABSTRACT | FULL TEXT  

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials
Haddad et al.
Mayo Clin Proc. 2007;82:29-39.
ABSTRACT | FULL TEXT  

Pathogenesis and Prevention of Bone Loss in Patients Who Have Kidney Disease and Receive Long-Term Immunosuppression
Cunningham
J. Am. Soc. Nephrol. 2007;18:223-234.
ABSTRACT | FULL TEXT  

Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
Wierman et al.
J. Clin. Endocrinol. Metab. 2006;91:3697-3710.
ABSTRACT | FULL TEXT  

Prevalence of hypogonadism in male patients with renal failure.
Albaaj et al.
Postgrad. Med. J. 2006;82:693-696.
ABSTRACT | FULL TEXT  

Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
Bhasin et al.
J. Clin. Endocrinol. Metab. 2006;91:1995-2010.
ABSTRACT | FULL TEXT  

Testosterone Use in Men and Its Effects on Bone Health. A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Tracz et al.
J. Clin. Endocrinol. Metab. 2006;91:2011-2016.
ABSTRACT | FULL TEXT  

Adverse Events Associated With Testosterone Replacement in Middle-Aged and Older Men: A Meta-Analysis of Randomized, Placebo-Controlled Trials
Calof et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:1451-1457.
ABSTRACT | FULL TEXT  

The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman and Vermeulen
Endocr. Rev. 2005;26:833-876.
ABSTRACT | FULL TEXT  

The Search for Safer Glucocorticoid Receptor Ligands
Rosen and Miner
Endocr. Rev. 2005;26:452-464.
ABSTRACT | FULL TEXT  

Activation of the vasoactive intestinal peptide 2 receptor modulates normal and atrophying skeletal muscle mass and force
Hinkle et al.
J. Appl. Physiol. 2005;98:655-662.
ABSTRACT | FULL TEXT  

Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects
Bonadonna et al.
Eur J Endocrinol 2005;152:199-205.
ABSTRACT | FULL TEXT  

Androgens and Bone
Vanderschueren et al.
Endocr. Rev. 2004;25:389-425.
ABSTRACT | FULL TEXT  

The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice
Weinstein et al.
Endocrinology 2004;145:1980-1987.
ABSTRACT | FULL TEXT  

Medical complications of lung transplantation
Kotloff and Ahya
Eur Respir J 2004;23:334-342.
ABSTRACT | FULL TEXT  

Suggested Guidelines for Evaluation and Treatment of Glucocorticoid-Induced Osteoporosis for the Department of Veterans Affairs
Adler and Hochberg
Arch Intern Med 2003;163:2619-2624.
ABSTRACT | FULL TEXT  

Osteoporosis in chronic obstructive pulmonary disease
Ionescu and Schoon
Eur Respir J 2003;22:64s-75s.
ABSTRACT | FULL TEXT  

Endocrinological disturbances in chronic obstructive pulmonary disease
Creutzberg and Casaburi
Eur Respir J 2003;22:76s-80s.
ABSTRACT | FULL TEXT  

Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment
Crawford et al.
J. Clin. Endocrinol. Metab. 2003;88:3167-3176.
ABSTRACT | FULL TEXT  

Management of corticosteroid-induced osteoporosis
Yeap and Hosking
Rheumatology (Oxford) 2002;41:1088-1094.
ABSTRACT | FULL TEXT  

Osteoporosis
Tuck and Francis
Postgrad. Med. J. 2002;78:526-532.
ABSTRACT | FULL TEXT  

Bone Density and Bone-Related Biochemical Variables in Normal Men: A Longitudinal Study
Scopacasa et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M385-391.
ABSTRACT | FULL TEXT  

Changes in Body Composition during Androgen Deprivation Therapy for Prostate Cancer
Smith et al.
J. Clin. Endocrinol. Metab. 2002;87:599-603.
ABSTRACT | FULL TEXT  

COPD and Osteoporosis
Biskobing
Chest 2002;121:609-620.
ABSTRACT | FULL TEXT  

Quality Indicators for the Management of Osteoporosis in Vulnerable Elders
Grossman and MacLean
ANN INTERN MED 2001;135:722-730.
FULL TEXT  

Prevention of Glucocorticoid-Induced Osteoporosis: Experience in a Managed Care Setting
Yood et al.
Arch Intern Med 2001;161:1322-1327.
ABSTRACT | FULL TEXT  

Suggested Rationale for Prevention and Treatment of Glucocorticoid-Induced Bone Loss in Dermatologic Patients
Yosipovitch et al.
Arch Dermatol 2001;137:477-481.
ABSTRACT | FULL TEXT  

Time to End Steroid-Induced Fractures
Reid
Arch Dermatol 2001;137:493-494.
FULL TEXT  

Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease*
Goldstein et al.
Chest 1999;116:1733-1749.
ABSTRACT | FULL TEXT  

Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
Reid
J Intensive Care Med 1999;14:231-242.
 

Management of bone disease in patients on long term glucocorticoid therapy
COMPSTON
Gut 1999;44:770-772.
FULL TEXT  

Prevention of corticosteroid induced osteoporosis
Lips
BMJ 1999;318:1366-1367.
FULL TEXT  

Glucocorticoid Effects on Bone
Reid
J. Clin. Endocrinol. Metab. 1998;83:1860-1862.
FULL TEXT  

Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis
Hajjar et al.
J. Clin. Endocrinol. Metab. 1997;82:3793-3796.
ABSTRACT | FULL TEXT  

Preventing Glucocorticoid-Induced Osteoporosis
Reid
NEJM 1997;337:419-421.
FULL TEXT  

Testosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih et al.
J. Clin. Endocrinol. Metab. 1997;82:1661-1667.
ABSTRACT | FULL TEXT  

Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing
MASI and CHROUSOS
Ann Rheum Dis 1997;56:1-4.
FULL TEXT  

Testosterone Treatment of Men Treated With Glucocorticoids
Odell
Arch Intern Med 1996;156:1133-1134.
ABSTRACT